NCT00879008已完成不适用
SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe AECB
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 345
- 主要终点
- Effectiveness and tolerance of/to the different therapies
研究概览
简要总结
In this study data of patients with moderate or severe acute exacerbations of chronic bronchitis (AECB) were collected. There were two different cohorts which were compared (Moxifloxacin and other antibiotics) concerning effectiveness and tolerance. It was a prospective study which was accomplished in 100 ambulatory practice offices.
详细描述
The study design was slightly changed to adapt the target population. Due to these changes the study was restarted on 8th December 2009.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Acute exacerbation of chronic bronchitis from Anthonisen type I or II
- •FEV1 of < 50 %
- •Patient must be ensured in the statutory health insurance
- •Further contraindications of the prescribed pharmaceutical products must be considered
排除标准
- •Patients who change from one cohort to the other
研究组 & 干预措施
Group 1
干预措施: Moxifloxacin (Avelox, BAY12-8039) (Drug)
结局指标
主要结局
Effectiveness and tolerance of/to the different therapies
时间窗: within the first 14 days
Possible hospitalisation rate
时间窗: within the first 14 days
次要结局
未报告次要终点
研究者
相似试验
招募中
不适用
3TR Asthma Biologics Cohort (ABC) StudySevere AsthmaNCT06126692Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)600
已完成
3 期
Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected AsthmaticsAsthmaNCT00252291Syntara240
已完成
不适用
Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary DiseaseChronic BronchitisNCT02128529AstraZeneca976
Unknown
不适用
Sputum Microbiota and the Association With Clinical Parameters in Steady-state, Acute Exacerbation and Convalescence of BronchiectasisBronchiectasisNCT02315547Guangzhou Institute of Respiratory Disease120
已完成
4 期
Evaluate the Efficacy and Safety of Acute Bronchitis Symptoms Improvement for Bronpass Tab. Compared to Erdos CapsuleAcute BronchitisNCT06038084Kwang-Ha Yoo110
